Nasal spray vaccine has potential for long-lasting protection from Ebola virus

3 noviembre 2014

A nasal vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. The Ebola virus is an often fatal illness that is spread among the human population via direct contact with blood or bodily fluids from an infected individual. The current Ebola outbreak in Western Africa is the largest and most complex epidemic since the virus was first discovered in 1976. With a fatality rate currently as high as 70%, officials are declaring this outbreak a public health emergency of international concern.